DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma

NCT04696029 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
118
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Giselle Sholler